MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Pediatric Tics and DCD: Motor Network Disorders?

M. Kuiper, R. Brandsma, W. Eggink, M. Egmond, J. de Vries, P. Hoekstra, A. Dietrich, D. Sival (Groningen, Netherlands)

Meeting: 2018 International Congress

Abstract Number: 461

Keywords: Development, Scales, Tics(also see Gilles de la Tourette syndrome): Pathophysiology

Session Information

Date: Saturday, October 6, 2018

Session Title: Pediatric Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To characterize and quantify pediatric tics and DCD according to specific movement disorder features.

Background: Until now, it has been impossible to attribute the pathophysiology of pediatric tics and developmental coordination disorders (DCD) to one uniform genetic cause, neuro-transmitter deficiency or cerebral structure. Our hypothesis is that idiopathic tics and DCD do not concern a homogeneous disorder, but rather a heterogeneous presentation of symptoms caused by various pathophysiologic abnormalities somewhere within the basal ganglia- and/or basal ganglia cerebellar network.

Methods: In children with idiopathic tics (n=30; aged 4-17 years) and DCD (n=10; aged 6-13 years) we phenotyped and quantified motor performances. Separate panels of 3-5 pediatric neurologists performed the phenotypic (indication of primary and/or secondary comorbid movement disorder features) and quantitative assessments by strict adherence to ataxia (SARA), dystonia (BFMMS) and chorea (Dyskinesia Impairment Scale–Chorea subscale (DIS-C)) rating scale guidelines. We determined (comorbid) movement disorder features that were recognized by the majority of assessors.

Results: Phenotypic assessment of pediatric tics revealed comorbid movement disorder features in 9/30 (30%) children with tics consisting of chorea, dystonia and myoclonus, but no ataxia. Phenotypic assessment of children with DCD revealed comorbid movement disorder features of ataxia and dystonia in 5/10 children (50%). The children with tics and DCD revealed significantly higher rating scale scores than age-related controls (Tics: SARA, BFMMS and DIS-C p<0.05, and DCD: SARA and DIS-C p<0.05), either still within (SARA, BFMMS) or just outside (DIS-C) the range of age-related normal values. Regression analysis showed that specifically tic phenotypes with choreatic features obtained higher total BFMMS and DIS-C scores (β=0.31, p=0.04 and β=0.43, p=0.014, respectively) than the other tic phenotypes.

Conclusions: Children with tics and DCD reveal heterogeneous features of comorbid movement disorders, potentially due to abnormal signal processing at different locations within the basal ganglia-, respectively cerebellar-thalamic-basal ganglia network connections. Future delineation of phenotypic sub-types may (1) contribute to the pathologic expression of these network connections and (2) aid genetic studies to elucidate underlying (modifying) gene defects.

To cite this abstract in AMA style:

M. Kuiper, R. Brandsma, W. Eggink, M. Egmond, J. de Vries, P. Hoekstra, A. Dietrich, D. Sival. Pediatric Tics and DCD: Motor Network Disorders? [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/pediatric-tics-and-dcd-motor-network-disorders/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/pediatric-tics-and-dcd-motor-network-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley